UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
RA CAPITAL MANAGEMENT, LLC C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVE., SUITE 610 BOSTON, MA 02199 |
 |  X |  |  |
ALDRICH RICHARD C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVE., SUITE 610 BOSTON, MA 02199 |
 |  X |  |  |
Kolchinsky Peter C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVE., SUITE 610 BOSTON, MA 02199 |
 |  X |  |  |
RA Capital Biotech Fund LP C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVE., SUITE 610 BOSTON, MA 02199 |
 |  X |  |  |
RA Capital Biotech Fund II, L.P. C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVE., SUITE 610 BOSTON, MA 02199 |
 |  X |  |  |
/s/ Peter Kolchinsky, Manager of RA Capital Management, LLC | 02/27/2008 | |
**Signature of Reporting Person | Date | |
Richard H. Aldrich | 02/27/2008 | |
**Signature of Reporting Person | Date | |
Peter Kolchinsky | 02/27/2008 | |
**Signature of Reporting Person | Date | |
Peter Kolchinsky, Manager of RA Capital Management, LLC, the General Partner of RA Capital Biotech Fund, L.P. | 02/27/2008 | |
**Signature of Reporting Person | Date | |
Peter Kolchinsky, Manager of RA Capital Management, LLC, the General Partner of RA Capital Biotech Fund II, L.P. | 02/27/2008 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | 1. Includes 29,472 shares held by RA Capital Biotech Fund, L.P. ("Fund I") and 528 shares held by RA Capital Biotech Fund II, L.P. ("Fund II") that were inadvertently omitted from the reporting persons' original Form 3. These shares were held prior to an acquisition of stock and warrants made by Fund I and Fund II on August 8, 2007. Currently, Fund I holds 7,417,674 shares and Fund II holds 132,890 shares. RA Capital Management, LLC (the "General Partner") is the general partner of each of Fund I and Fund II, and Richard H. Aldrich and Peter Kolchinsky are the sole managers of the General Partner. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the exten of his or her pecuniary interest therein, if any. |